Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Edwina N Scott, Gerold Meinhardt, Christian Jacques, Dirk Laurent & Anne L Thomas. (2007) Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours. Expert Opinion on Investigational Drugs 16:3, pages 367-379.
Read now
Read now
Kelly A Healy, Fray F Marshall & Kenneth Ogan. (2006) Cytoreductive nephrectomy in metastatic renal cell carcinoma. Expert Review of Anticancer Therapy 6:8, pages 1295-1304.
Read now
Read now
Articles from other publishers (11)
Haibao Zhang & Guodong Zhu. (2020) Beyond Promoter: The Role of Macrophage in Invasion and Progression of Renal Cell Carcinoma. Current Stem Cell Research & Therapy 15:7, pages 588-596.
Crossref
Crossref
Bernardo L Rapoport. (2015) Sorafenib: a brief review with emphasis on its possible role in breast cancer. Breast Cancer Management 4:2, pages 99-110.
Crossref
Crossref
Leonid L. Nikitenko, Russell Leek, Stephen Henderson, Nischalan Pillay, Helen Turley, Daniele Generali, Sarah Gunningham, Helen R. Morrin, Andrea Pellagatti, Margaret C.P. Rees, Adrian L. Harris & Stephen B. Fox. (2013) The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis. Clinical Cancer Research 19:20, pages 5740-5748.
Crossref
Crossref
Laura Q. M. Chow & S. Gail Eckhardt. 2011. Principles of Anticancer Drug Development. Principles of Anticancer Drug Development
347
401
.
Michael F. Ochs, John T. Casagrande & Ramana V. Davuluri. 2010. Biomedical Informatics for Cancer Research. Biomedical Informatics for Cancer Research
3
15
.
Y. Huang, Y. Dai, J. Yang, T. Chen, Y. Yin, M. Tang, C. Hu & L. Zhang. (2009) Microarray analysis of microRNA expression in renal clear cell carcinoma. European Journal of Surgical Oncology (EJSO) 35:10, pages 1119-1123.
Crossref
Crossref
HRH Patel, A Amodeo & JV Joseph. (2009) Robotic Oncological Surgery: Technology That's Here to Stay?. International Journal of Advanced Robotic Systems 6:3, pages 28.
Crossref
Crossref
Nastaran Monsef, Leszek Helczynski, Åke Lundwall, Sven Påhlman & Anders-Bjartell. (2007) Localization of immunoreactive HIF-1α and HIF-2α in neuroendocrine cells of both benign and malignant prostate glands. The Prostate 67:11, pages 1219-1229.
Crossref
Crossref
Matthew I. Milowsky, David M. Nanus, Lale Kostakoglu, Christine E. Sheehan, Shankar Vallabhajosula, Stanley J. Goldsmith, Jeffrey S. Ross & Neil H. Bander. (2007) Vascular Targeted Therapy With Anti–Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors. Journal of Clinical Oncology 25:5, pages 540-547.
Crossref
Crossref
Kate McKeage & Antona J Wagstaff. (2007) Sorafenib. Drugs 67:3, pages 475-483.
Crossref
Crossref
Caren L Hughes, Winston W Tan & Marcus Ferrone. (2016) Sorafenib for the Treatment of Renal Cell Carcinoma. Journal of Pharmacy Technology 22:5, pages 281-288.
Crossref
Crossref